|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net - Note H | ||||||||||||||||||||
| Inventories - Note F | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Current assets held for sale - Note B | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Noncurrent assets | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Cost | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Net property, plant and equipment | ||||||||||||||||||||
| Goodwill - Note G | ||||||||||||||||||||
| Intangibles, net - Note G | ||||||||||||||||||||
| Operating lease assets, net - Note I | ||||||||||||||||||||
| Restricted investments - Note E | ||||||||||||||||||||
| Asbestos insurance receivable, net - Note L | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Short-term debt - Note H | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Trade and other payables | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Current operating lease obligations - Note I | ||||||||||||||||||||
| Current liabilities held for sale - Note B | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Noncurrent liabilities | ||||||||||||||||||||
| Long-term debt - Note H | ||||||||||||||||||||
| Asbestos litigation reserves - Note L | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Employee benefit obligations - Note K | ||||||||||||||||||||
| Operating lease obligations - Note I | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total noncurrent liabilities | ||||||||||||||||||||
| Common stock, par value $.01 per share, 200 million shares authorized Issued 46 million and 47 million shares in 2025 and 2024 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Equity - Note N | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
